Glad to share the finalized version of a Haematologica review by @raajitrampal.bsky.social and me focused on accelerated/blast-phase MPNs! haematologica.org/article/view...

Out today in @NatureMedicine phase 3 data from thh MANIFEST-2 study nature.com/articles/s41... @aarongerds.bsky.social @mpndoc.bsky.social @kuykendallmd.bsky.social @rubenmesamd.bsky.social

@mskcancercenter.bsky.social cycle for survival! Time to ride and raise money for rare cancers

1. Today the NIH director issued a new directive slashing overhead rates to 15%. I want to provide some context on what that means and why it matters. grants.nih.gov/grants/guide...

Important report in @nejm.org from @mskcancercenter.bsky.social CD4+ T-Cell Lymphoma Harboring a Chimeric Antigen Receptor Integration in TP53 #CARTcells #mmsm www.nejm.org/doi/full/10....

I just registered for Cycle for Survival to support MPN research at MSKCC. My ride is March 7 and I’m trying to raise as much as I can by then to help people with MPNs Make your 100% tax-deductible donation here secure2.convio.net/mskcc/site/T...

#REVIEW Vallot, Lupien and Lasine describe how epigenomic heterogeneity generates dynamic reservoirs of tumour cell states, which can be leveraged in the design of novel therapies. 📖 👉 https://bit.ly/40PCQ...